CBIO Crescent Biopharma, Inc.

NASDAQ
$13.99

Crescent Biopharma, Inc. (CBIO) Hedge Fund Activity

This view isolates hedge funds from the broader institutional ownership shown on the Institutional tab. A pension fund tracking an index may have no view on a stock; when a hedge fund builds or exits a position, that decision can carry information. This page measures those changes. Positions as of June 30, 2026.

Based on quarterly 13F long-equity filings. Changes compare reported quarter-end positions; filings can be reported up to 45 days later and do not represent a fund's complete exposure.

Hedge fund breadth
+12.50
9 buyers / 7 sellers
BUYING
Funds compared
22
funds with comparable CBIO positions
16 current holders · 20 prior-quarter holders
Net share change
+1.05M
+1.96M added, -907.3K cut
Position activity
2 new 7 increased 1 reduced 6 exited

Most significant moves

Ranked by conviction, not size — how much of the fund's own book the position represents, how far it moved, and what kind of fund made it.

Fund Action Shares changed Change Est. value Portfolio wt. Score
Deep Track Capital Growth Healthcare Sold Out -453.7K -100.0% $8.2M 0.0% 63
Logos Global Management Growth Healthcare Increased +1.42M +293.8% $25.5M 1.5% 61
RENAISSANCE TECHNOLOGIES LLC Quant Sold Out -24.3K -100.0% $436.7K 0.0% 58
Alyeska Investment Group, L.P. Sold Out -264.0K -100.0% $4.8M 0.0% 58
Hudson Bay Capital Management Event Sold Out -88.9K -100.0% $1.6M 0.0% 55
Squarepoint Ops LLC Quant New +24.2K — $435.0K 0.0% 54
Lighthouse Investment Partners Sold Out -25.0K -100.0% $450.0K 0.0% 51
Brevan Howard Capital Management Macro Sold Out -19.5K -100.0% $351.5K 0.0% 49
Y-Intercept Quant New +50.8K — $914.8K 0.0% 48
TWO SIGMA INVESTMENTS, LP Quant Increased +71.0K +61.3% $1.3M 0.0% 43

Most significant buyers

By move score, not size.

  • Logos Global Management Increased · +1.42M
  • Squarepoint Ops LLC New · +24.2K
  • Y-Intercept New · +50.8K
  • TWO SIGMA INVESTMENTS, LP Increased · +71.0K
  • Vestal Point Capital Increased · +130.0K

Most significant sellers

By move score, not size.

  • Deep Track Capital Sold Out · -453.7K
  • RENAISSANCE TECHNOLOGIES LLC Sold Out · -24.3K
  • Alyeska Investment Group, L.P. Sold Out · -264.0K
  • Hudson Bay Capital Management Sold Out · -88.9K
  • Lighthouse Investment Partners Sold Out · -25.0K

Hedge fund positions

Fund Tier Shares Previous Change Change % Portfolio wt. Action Score
Deep Track Capital 1 0 453.7K -453.7K -100.0% 0.0% Sold Out 63
Logos Global Management 2 1.9M 482.5K +1.42M +293.8% 1.5% Increased 61
RENAISSANCE TECHNOLOGIES LLC 1 0 24.3K -24.3K -100.0% 0.0% Sold Out 58
Alyeska Investment Group, L.P. 2 0 264.0K -264.0K -100.0% 0.0% Sold Out 58
Hudson Bay Capital Management 3 0 88.9K -88.9K -100.0% 0.0% Sold Out 55
Squarepoint Ops LLC 2 24.2K 0 +24.2K — 0.0% New 54
Lighthouse Investment Partners 3 0 25.0K -25.0K -100.0% 0.0% Sold Out 51
Brevan Howard Capital Management 3 0 19.5K -19.5K -100.0% 0.0% Sold Out 49
Y-Intercept 4 50.8K 0 +50.8K — 0.0% New 48
TWO SIGMA INVESTMENTS, LP 2 186.9K 115.8K +71.0K +61.3% 0.0% Increased 43
ADAR1 Capital Management 3 18.3K 50.3K -32.0K -63.6% 0.0% Reduced 38
Vestal Point Capital 1 1.6M 1.5M +130.0K +8.7% 0.7% Increased 35
MILLENNIUM MANAGEMENT LLC 2 403.9K 323.6K +80.3K +24.8% 0.0% Increased 34
Balyasny Asset Management L.P. 2 1.7M 1.5M +152.9K +10.1% 0.1% Increased 31
Woodline Partners LP 2 94.5K 74.0K +20.5K +27.7% 0.0% Increased 30
MARSHALL WACE, LLP 2 214.3K 200.8K +13.5K +6.7% 0.0% Increased 27
Biotechnology Value Fund 1 2.7M 2.7M 0 +0.0% 1.3% Unchanged 30
Tang Capital Management 2 1.2M 1.2M 0 +0.0% 1.0% Unchanged 25
RTW Investments 1 372.9K 372.9K 0 +0.0% 0.1% Unchanged 25
Point72 Asset Management, L.P. 1 300.0K 300.0K 0 +0.0% 0.0% Unchanged 23
Perceptive Advisors 1 206.9K 206.9K 0 +0.0% 0.1% Unchanged 24
Moore Capital Management 3 25.0K 25.0K 0 +0.0% 0.0% Unchanged 16

Every fund above opens. Subscribers can see any manager's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Hedge funds are identified from their 13F filings, which are due 45 days after quarter end and cover long U.S.-listed equity positions only. A fund's short book never appears, so a reduced position can mean a changed view or a changed hedge — the filing doesn't say which.